ADC Therapeutics SA (ADCT) vs Canopy Growth Corporation (CGC)

ADC Therapeutics SA and Canopy Growth Corporation are both Drug Manufacturers Specialty & Generic companies. Canopy Growth Corporation is the larger, with a market value of $283.5M against $209.4M — 1.4× the size. Canopy Growth Corporation grew revenue faster over the last twelve months: 7.80% against 3.03%. Canopy Growth Corporation has the higher net margin (−80.4% vs −121.8%) and the lower return on invested capital (−17.2% vs 0.00%). Across the 17 metrics below, Canopy Growth Corporation leads on 11 and ADC Therapeutics SA on 6.

Valuation

Metric ADCT CGC Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 3.23 1.35 2.08
P/B n/m 0.58 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 1.95 1.01 2.87
Earnings yield (39.76%) (65.34%) (15.94%)
Free cash flow yield (39.53%) (21.13%) 0.00%

Profitability

Metric ADCT CGC Drug Manufacturers Specialty & Generic median
Gross margin 88.86% 25.16% 53.51%
Operating margin (125.08%) (54.89%) 0.00%
Net margin (121.77%) (80.39%) (2.45%)
Free cash flow margin (127.72%) (28.34%) 0.00%
Return on equity 45.35% (40.14%) (0.80%)
Return on assets (32.25%) (23.54%) (1.67%)
Return on invested capital 0.00% (17.19%) 0.00%

Growth

Metric ADCT CGC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 3.03% 7.80% 5.22%
EPS growth (last fiscal year) 30.86% 84.00% 42.91%
Revenue growth, 5-year CAGR 103.35% (13.04%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADCT CGC Drug Manufacturers Specialty & Generic median
Debt to equity (0.51) 0.35 0.04
Current ratio 3.03 3.04 2.41
Net debt to EBITDA 1.22 1.09 1.01

Dividend

Metric ADCT CGC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric ADCT CGC Drug Manufacturers Specialty & Generic median
Market cap 209.38m 283.50m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack